The need for validation of MI GPSai in patients with CUP: Comment on: "Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type" by J Abraham et al.
作者信息
Greco F Anthony
机构信息
Sarah Cannon Research Institute, Nashville, TN, 32703, USA; Tennessee Oncology, Nashville, TN, 32703, USA.
出版信息
Transl Oncol. 2021 Aug;14(8):101092. doi: 10.1016/j.tranon.2021.101092.
Abstract
摘要
相似文献
1
The need for validation of MI GPSai in patients with CUP: Comment on: "Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type" by J Abraham et al.
Transl Oncol. 2021 Aug;14(8):101092. doi: 10.1016/j.tranon.2021.101092.
2
Response to "The need for validation of MI GPSai in patients with CUP: Comment on: "Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type" by J Abraham et al.".
Transl Oncol. 2021 Aug;14(8):101093. doi: 10.1016/j.tranon.2021.101093.
3
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type.
Transl Oncol. 2021 Mar;14(3):101016. doi: 10.1016/j.tranon.2021.101016. Epub 2021 Jan 16.
4
Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
Front Cell Dev Biol. 2021 May 3;9:619330. doi: 10.3389/fcell.2021.619330. eCollection 2021.
5
Predicting the Postoperative Outcome of Percutaneous Nephrolithotomy with Machine Learning System: Software Validation and Comparative Analysis with Guy's Stone Score and the CROES Nomogram by Aminsharifi et al. (J Endourol 2020;34(6):692-699; DOI: 10.1089/end.2019.0475).
J Endourol. 2020 Jun;34(6):699-700. doi: 10.1089/end.2020.0203. Epub 2020 Apr 21.
6
EL-Nahas, Editorial Comment on: Predicting the Postoperative Outcome of Percutaneous Nephrolithotomy with Machine Learning System: Software Validation and Comparative Analysis with Guy's Stone Score and the CROES Nomogram by Aminsharifi et al. (J Endourol 2020;34(6):699-700; DOI: 10.1089/end.2020.0203).
J Endourol. 2020 Jun;34(6):700-701. doi: 10.1089/end.2020.29085.alm.
7
Myocardial infarction in type 2 diabetes using sodium-glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 receptor agonists: proportional hazards analysis by deep neural network based machine learning.
Curr Med Res Opin. 2020 Mar;36(3):403-409. doi: 10.1080/03007995.2019.1706043. Epub 2020 Jan 6.
8
Personal Health Information Inference Using Machine Learning on RNA Expression Data from Patients With Cancer: Algorithm Validation Study.
J Med Internet Res. 2020 Aug 10;22(8):e18387. doi: 10.2196/18387.
9
Editorial Comment on: Utilizing Machine Learning and Automated Performance Metrics to Evaluate Robot-Assisted Radical Prostatectomy Performance and Predict Outcomes by Hung et al.
J Endourol. 2018 May;32(5):445. doi: 10.1089/end.2018.0209. Epub 2018 Apr 26.
10
Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298-2306.
Diabetes Care. 2020 Feb;43(2):e26-e27. doi: 10.2337/dci19-0059.
本文引用的文献
1
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type.
Transl Oncol. 2021 Mar;14(3):101016. doi: 10.1016/j.tranon.2021.101016. Epub 2021 Jan 16.
2
Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine.
Am Soc Clin Oncol Educ Book. 2018 May 23;38:20-25. doi: 10.1200/EDBK_100014.
3
Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay.
Mol Diagn Ther. 2015 Apr;19(2):91-7. doi: 10.1007/s40291-015-0133-8.
4
Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
J Natl Cancer Inst. 2013 Jun 5;105(11):782-90. doi: 10.1093/jnci/djt099. Epub 2013 May 2.
5
Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors.
J Mol Diagn. 2013 Mar;15(2):263-9. doi: 10.1016/j.jmoldx.2012.10.001. Epub 2012 Dec 31.
6
Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction.
Oncologist. 2010;15(5):500-6. doi: 10.1634/theoncologist.2009-0328. Epub 2010 Apr 28.
7
Diagnostic strategies for unknown primary cancer.
Cancer. 2004 May 1;100(9):1776-85. doi: 10.1002/cncr.20202.
Zotero 插件